Cite
MLA Citation
Andrea Koch et al.. “Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat® device for maintenance treatment of COPD: comparison with the long-acting β2-agonist formoterol.” NPJ primary care respiratory medicine, vol. 27, 2017, pp. 1–6. http://access.bl.uk/ark:/81055/vdc_100084819501.0x000084